A Clinical Study to Evaluate the Efficacy and Safety of LIV-GAMMA SN Inj.10% in Primary Immune Thrombocytopenia (ITP)

Clinical trial NCT05566990 · COMPLETED

Trial details

NCT number: NCT05566990
Sponsor: SK Plasma Co., Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Immune Thrombocytopenia

Start date: 2019-07-19
Primary completion: 2021-06-03
Enrollment: 34

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.